GTBP Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

GT Biopharma Inc (GTBP) Moving Averages Convergence Divergence (MACD) indicator is 0.0174, suggesting GTBP is Buy.

GT Biopharma Inc (GTBP) 20-Day simple moving average is 0.394, while GT Biopharma Inc (GTBP) share price is $0.449, making it Buy.

GT Biopharma Inc (GTBP) 60-Day simple moving average is 0.399, while GT Biopharma Inc (GTBP) share price is $0.449, making it Buy.

Technical Analysis for GTBP

Technical Sentiment Analysis for GT Biopharma Inc (GTBP) As of 2026-05-29, GT Biopharma Inc (GTBP) is exhibiting a Buy technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 8 indicators are flashing buy, while 5 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for GTBP stands at 60.956, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.0174, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 71.451 and the Commodity Channel Index (CCI) at 163.501 further confirm a 0.0393 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, GTBP is trading below its 60-day moving average of $0.399 and below its 200-day long-term moving average of $0.635. Key price levels to watch include the immediate resistance at $0.489 and strong support at $0.355. A break above $0.489 could signal a bull continuation, while falling below $0.355 may test the next Fibonacci floor at $0.291.

GT Biopharma Inc (GTBP) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	0.221	0.291	0.355	0.425	0.489	0.559	0.623
Fibonacci	0.291	0.342	0.374	0.425	0.476	0.508	0.559

GT Biopharma Inc (GTBP) Technical Indicators

2026-05-29

Name	Value
RSI_14	60.956
STOCHk_14_3_3	71.451
STOCHd_14_3_3	61.103
CCI_20	163.501
AO_5_34	0.0566
MOM_10	0.0393
MACD_12_26_9	0.0174

GT Biopharma Inc (GTBP) Relative Strength Index (RSI) is 60.956, creating a Neutral signal.

GT Biopharma Inc (GTBP) Stochastic Oscillator is 71.451, creating a Neutral signal.

GT Biopharma Inc (GTBP) Stochastic RSI is 61.103, creating a Neutral signal.

GT Biopharma Inc (GTBP) Commodity Channel Index (CCI) is 163.501, creating a Sell signal.

GT Biopharma Inc (GTBP) Awesome Oscillator is 0.0566, creating a Buy signal.

GT Biopharma Inc (GTBP) Momentum is 0.0393, creating a Buy signal.

GT Biopharma Inc (GTBP) MACD is 0.0174, creating a Buy signal.

GT Biopharma Inc (GTBP) Moving Average

2026-05-29

Period	Simple	Signal
MA_5	0.43	Buy
MA_10	0.419	Buy
MA_20	0.394	Buy
MA_60	0.399	Buy
MA_200	0.635	Sell
MA_250	1.004	Sell

GT Biopharma Inc (GTBP) 5-Day simple moving average is 0.43, while GT Biopharma Inc (GTBP) share price is $0.449, making it a Buy.

GT Biopharma Inc (GTBP) 10-Day simple moving average is 0.419, while GT Biopharma Inc (GTBP) share price is $0.449, making it a Buy.

GT Biopharma Inc (GTBP) 20-Day simple moving average is 0.394, while GT Biopharma Inc (GTBP) share price is $0.449, making it a Buy.

GT Biopharma Inc (GTBP) 60-Day simple moving average is 0.399, while GT Biopharma Inc (GTBP) share price is $0.449, making it a Buy.

GT Biopharma Inc (GTBP) 200-Day simple moving average is 0.635, while GT Biopharma Inc (GTBP) share price is $0.449, making it a Sell.

GT Biopharma Inc (GTBP) 250-Day simple moving average is 1.004, while GT Biopharma Inc (GTBP) share price is $0.449, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for GTBP?

The overall technical consensus for GT Biopharma Inc (GTBP) is currently Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 3 sell signals.

What are the key support and resistance levels for GT Biopharma Inc (GTBP) today?

Based on pivot point calculations, GT Biopharma Inc (GTBP) has an immediate support level at 0.355 and a major resistance level at 0.489. Traders also monitor the pivot point at 0.425 to determine the intraday trend direction.

Is GT Biopharma Inc (GTBP) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for GT Biopharma Inc (GTBP) is currently 60.956. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for GT Biopharma Inc (GTBP)?

GT Biopharma Inc (GTBP) Moving Averages Convergence Divergence (MACD) indicator is 0.0174, suggesting GTBP is Buy. This indicator helps identify potential trend reversals or momentum shifts for GT Biopharma Inc.

How is GT Biopharma Inc (GTBP) performing relative to its 200-day moving average?

GT Biopharma Inc (GTBP) is currently trading at $0.449, which is below its 200-day simple moving average of 0.635. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.